\n| Subject<\/td>\n | \nAnnouncement of the resolution by the Company\r\nfor the ex-dividend record date of cash dividends.<\/pre>\n<\/td>\n<\/tr>\n\n| Date of events<\/td>\n | \u00a02026\/03\/16<\/td>\n | To which item it meets<\/td>\n | paragraph 14<\/td>\n<\/tr>\n | \n| Statement<\/td>\n | \n1.Date of the resolution by the board of directors or \r\n shareholders meeting or decision by the Company:\r\n 2026\/03\/16\r\n2.Type of ex-rights or ex-dividend (please enter: \r\n \u201cEx-rights\u201d,\u201dEx-dividend\u201d, or \u201dEx-rights and \r\n dividend\u201d): Ex-dividend\r\n3.Type and monetary amount of common stock dividend \r\n distribution: Cash dividends NT$809,980,061, per \r\n share distributed NT$4.30 (NT$4,300 per thousand \r\n shares). Furthermore, the cash dividend shall be \r\n calculated to the nearest dollar and the decimal \r\n figures shall be rounded off.The amount rounded off\r\n from the current of cash dividend shall be listed \r\n as the Company's other income. In case of any \r\n change in the per-share cash dividend as a result \r\n of the fact that repurchase of the Company's shares,\r\n the treasury stock is transferred or deleted, or \r\n carries out a cash capital increase, which further \r\n affects the number of the Company's outstanding \r\n shares. The chairman shall be authorized to adjust the \r\n shareholder's cash dividend rate according to the \r\n distribution amount adopted for this proposal and the\r\n number of the Company's actual outstanding shares.\r\n4.Ex-rights (ex-dividend) trading date:2026\/04\/23\r\n5.Last date before book closure:2026\/04\/26\r\n6.Book closure starting date:2026\/04\/27\r\n7.Book closure ending date:2026\/05\/01\r\n8.Ex-rights (ex-dividend) record date:2026\/05\/01\r\n9.Deadline for applying the conversion of the bond:\r\n Not Applicable.\r\n10.The closure period for the conversion of the bond will \r\n start from the date:Not Applicable.\r\n11.The closure period for the conversion of the bond will\r\n end on the date:Not Applicable.\r\n12.Payment date of common stock cash dividend \r\n distribution:2026\/05\/21\r\n13.Any other matters that need to be specified:\r\n (1)The last date before book closure (April 26, 2026) \r\n falls on a holiday,so shareholders shall go in \r\n person to the Transfer Agency Department of \r\n President Securities Co.,Ltd. (B1., No. 8, Dongxing\r\n Rd., Songshan Dist.,Taipei City) for transfer of \r\n share ownership before 4:30 p.m. on April 24,2026.\r\n For the registered mailer operation, the postmark \r\n date of April 26,2026 will be considered valid.\r\n (2)This dividend distribution notice is also being \r\n handled through \u201ceNotice Platform\u201d by the Taiwan \r\n Depository & Clearing Corporation (TDCC). \r\n Shareholders are kindly requested to log into the \r\n website: https:\/\/stockservices.tdcc.com.tw and \r\n register their consent to receive electronic\r\n notifications of dividend distribution via the \r\n eNotice Platfrom one business day prior to the \r\n Ex-right\/ Ex-dividend book closure date (i.e., \r\n before April 23, 2026).By doing so,shareholders\r\n can receive the dividend distribution notice via\r\n email. (For those who provide their consent after \r\n April 24, 2026, the electronic notification will \r\n apply to the next dividend distribution.)\r\n<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":" SEQ_NO \u00a01 Date of announcement 2026\/03\/16 Time of announcement 17:14:37 Subject Announcement of the resolution by the Company for the ex-dividend record date of cash dividends. Date of events \u00a02026\/03\/16 To which item it meets paragraph 14 Statement 1.Date of the resolution by the board of directors or shareholders meeting or decision by the …<\/p>\n Announcement of the resolution by the Company for the ex-dividend record date of cash dividends.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[102,72],"tags":[],"class_list":["post-10284","post","type-post","status-publish","format-standard","hentry","category-material-information","category-investors"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=10284"}],"version-history":[{"count":3,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10284\/revisions"}],"predecessor-version":[{"id":10293,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10284\/revisions\/10293"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=10284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=10284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=10284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} | |